| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $110.5M | -34.4% |
| R&D Expense | $227.7M | -10.2% |
| SG&A Expense | $61.2M | +14.7% |
| Operating Income | -$178.4M | -28.7% |
| Pre-tax Income | -$234.9M | -95.1% |
| Income Tax | $1.6M | -72.2% |
| Net Income | -$232.6M | -84.5% |
| EPS (Basic) | -$3.58 | -72.1% |
| EPS (Diluted) | -$3.58 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $40.9M | -24.0% |
| Accounts Receivable | $60.8M | +439.0% |
| Current Assets | $577.6M | -7.3% |
| Total Assets | $951.9M | -0.1% |
| Current Liabilities | $87.4M | +3.2% |
| Long-term Debt | $115.2M | +686.5% |
| Total Liabilities | $277.9M | -2.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$202.2M | -337.6% |
| Capital Expenditures | $6.1M | -67.0% |
| Investing Cash Flow | -$7.9M | +92.9% |
| Financing Cash Flow | $197.2M | +653.0% |
| Free Cash Flow | -$208.3M | -412.4% |
| -72.1% |
| Stockholders' Equity |
| $677.6M |
| +1.3% |